MBX - Company ID 0001776111
The table below shows MBX Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|
| Cash & equivalents | $45.21M | $223.13M | $39.78M | $29.90M | $132.87M |
| Short-term investments | $394.76M | $168.55M | $185.13M | $210.88M | $144.20M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $448.54M | $397.50M | $229.19M | $244.28M | $281.17M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $3.13M | $2.00M | $1.73M | $1.51M | $1.03M |
| Goodwill | - | - | - | - | - |
| Total assets | $452.70M | $400.08M | $231.52M | $245.93M | $282.40M |
| Accounts payable | $6.97M | $3.77M | $5.76M | $4.25M | $5.00M |
| Total current liabilities | $14.57M | $12.06M | $11.76M | $10.48M | $10.92M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $14.95M | $12.54M | $12.28M | $10.50M | $11.03M |
| Retained earnings | -$247.99M | -$202.41M | -$180.80M | -$161.38M | -$121.92M |
| Total equity | $437.76M | $387.54M | $219.24M | $235.42M | $271.37M |